Results:
The mean age of the patients participating in the study was 30.8 ± 6.05 years. The mean baseline total sperm count was 53.86 million in the Proxeed group and 49.82 million in the Carniact group, with no significant difference between the groups (p> 0.05). However, there was a statistically significant difference between the two groups in terms of the pre-treatment baseline sperm motility and morphology parameters (p<0.05) (Table 2). There was a significant difference between the baseline and sixth-month total sperm counts ​​of the patients in each of the two groups (p<0.05) (Table 3 and 4). However, no significant changes were found in total semen volume in the Proxeed group and non-progressive motility in the Carniact group after treatment (p> 0.05). There was also no statistically significant difference between the two groups in terms of post-treatment parameters (p>0.05) (Table 5).
Table 2 : Comparision groups before treatment